A 24 yuan cancer medicine becomes difficult to find Injectable cyclophosphamide, a chemotherapy medicine normally listed at about 24 yuan per vial in China, has been offered online for 600 to 650 yuan during a shortage that has disrupted hospital…

Piramal Pharma Solutions and NP2 will finalize the development phase of the generic cancer drug, Cyclophosphamide, in October 2026, enhancing supply security.

Piramal Pharma Solutions and NP2 are set to complete the cyclophosphamide development phase by next month, aiming to enhance cancer drug availability.

Piramal Pharma Solutions partners with NP2 to complete the development phase of cyclophosphamide, addressing critical shortages in cancer treatment.

Piramal Pharma Solutions and NP2 aim to finish developing cyclophosphamide, a crucial cancer treatment drug, next month in a bid to ensure a stable supply for patients.

An observational analysis showed a long-term OS benefit with Orca-T in adult patients undergoing allogeneic transplantation for hematologic malignancies.

Read the full paper: Differential heat shock protein transcript expression in mouse lower urinary tract (LUT) pathways in cyclophosphamide (CYP)-induced cystitis or repeated variate stress (RVS)

Background and objectives: Ganoderma species are widely used in traditional medicine for their immunomodulatory properties. However, systematic evaluations of indigenous Vietnamese taxa remain limited...

OPTIMUM shows sustained progression-free survival and overall survival improvement with risk-stratified extended therapy, supporting implementation of molecular diagnostics and tailored treatment in p...

Ewing sarcoma (ES) is a malignant bone tumor with high relapse rates, especially in multi-metastatic disease despite multimodal treatment. The role of maintenance therapy in ES remains undefined. We systematically reviewed clinical trial data to assess the feasibility and rationale for maintenance therapy in localized and metastatic disease, with the aim to help selecting drugs to introduce as maintenance therapy within the trial.

Cardiac involvement, which may remain clinically silent, is a major determinant of prognosis in eosinophilic granulomatosis with polyangiitis (EGPA), and remission induction generally requires glucocorticoids combined with cyclophosphamide or rituximab. In contrast, treatment selection may be challe …

UCL Discovery is UCL's open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.

A 59-year-old man presented with sore throat and cough, and chest computed tomography and bronchoscopy revealed airway stenosis. Four McAdam's criteria supported the diagnosis of relapsing polychondritis. High-dose prednisolone and cyclophosphamide improved symptoms and airway lesions, highlighting …

The standard 100 mg/kg dose of post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis after matched allogeneic stem cell transplantation (ASCT) is associated with imp...